☆ 4.4 Meeting Abstract

IMPACT OF ELEXACAFTOR/TEZACAFTOR/IVACAFTOR TRIPLE COMBINATION THERAPY ON HEALTH-RELATED QUALITY OF LIFE IN PEOPLE WITH CYSTIC FIBROSIS HETEROZYGOUS FOR F508DEL AND A MINIMAL FUNCTION MUTATION: RESULTS FROM A PHASE 3 CLINICAL STUDY

PEDIATRIC PULMONOLOGY (2020)

Rate this paper

The primary rating indicates the level of overall quality for the paper. Secondary ratings independently reflect strengths or weaknesses of the paper.

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

IMPACT OF ELEXACAFTOR/TEZACAFTOR/IVACAFTOR TRIPLE COMBINATION THERAPY ON HEALTH-RELATED QUALITY OF LIFE IN PEOPLE WITH CYSTIC FIBROSIS HETEROZYGOUS FOR F508DEL AND A MINIMAL FUNCTION MUTATION: RESULTS FROM A PHASE 3 CLINICAL STUDY

Rate this paper

Add your recorded webinar

Become a Peeref-certified reviewer

Export Citation

Share Paper